Skip to content

Study held to see the effect of yapan basti on post covid 19 symptoms

A single arm clinical study to evaluate the efficacy of sahachradi yapan basti in the management of post covid -19 symptoms

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038239
Enrollment
60
Registered
2021-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified Health Condition 2: J989- Respiratory disorder, unspecified

Interventions

None listed

Sponsors

Dr Pratima Naresh Gawand
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients suffering from post covid 19 symptoms will be taken as a subject to study age above 20 yrs and not less than 60

Exclusion criteria

Exclusion criteria: patients with mucormycosis patients with bronchioalveolar carcinoma

Design outcomes

Primary

MeasureTime frame
sahacharadi yapan basti is effective in post covid 19 symptoms subjective criteria will be 1)fatique 2)dysapnea 3)cough 4)myalgia objective crieteria 1)cbc 2)c reative protein 3)esr 4)6 min walking test 5)lung function testTimepoint: 16 days with follow 3 follow up (8,17,32 days)

Secondary

MeasureTime frame
reduction in grades of post covid 19 symptoms like lung capacity improvement will be studiedTimepoint: 16 days with follow 3 follow up (8,17,32 days)

Countries

India

Contacts

Public ContactDr Pratima Naresh Gawand

Dr D Y patil college of Ayurveda and research centre

mamtaraut1966@gmail.com9850241887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026